Oncology Vol 30 No 2

Langerhans Cell Histiocytosis Enters the Genomics Age

February 15, 2016

This increased understanding of the pathophysiology of Langerhans cell histiocytosis should help guide treatment and therapies and provides the rationale for using agents effective against myeloid malignancies.

The Immunocompromised Traveler

February 15, 2016

Among immunocompromised travelers, the risk of acquiring travel-related infections may be higher due to deficits in their immune system and their potential to have attenuated responses to vaccines.